<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35435150</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1555-8576</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biology &amp; therapy</Title>
          <ISOAbbreviation>Cancer Biol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines.</ArticleTitle>
        <Pagination>
          <StartPage>328</StartPage>
          <EndPage>335</EndPage>
          <MedlinePgn>328-335</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/15384047.2022.2058862</ELocationID>
        <Abstract>
          <AbstractText>Curcumin, the primary bioactive component isolated from turmeric, has been found to possess a variety of biological functions, including anti-leukemia activity. However, the effect of curcumin in different leukemia cells vary. In this study, we demonstrated that curcumin induced the expression of AIM2, IFI16, and NLRC4 inflammasomes in leukemia cells U937 by increasing the expression levels of ISG3 transcription factor complex, which activated caspase 1, promoted cleavage of GSDMD, and induced pyroptosis. We also found that pyroptosis executor GSDMD was not expressed in two curcumin-insensitive cells HL60 and K562 cells. In addition, exogenous overexpression of GSDMD by lentiviral transduction in K562 cells increased the anti-cancer activity of curcumin, and inhibiting the expression of GSDMD by shRNA enhanced U937 cells to resist curcumin. The results showed that inducing pyroptosis is a novel mechanism underlying the anti-leukemia effects of curcumin.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yuru</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0003-4604-0019</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>JiangXi Key Laboratory of Transfusion Medicine, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kong</LastName>
            <ForeName>Yunyuan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Examination, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuang</LastName>
            <ForeName>Linju</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wan</LastName>
            <ForeName>Jinhua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Shuyuan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Qian</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>JiangXi Key Laboratory of Transfusion Medicine, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Kuai</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>JiangXi Key Laboratory of Transfusion Medicine, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Na</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0001-9230-7998</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le</LastName>
            <ForeName>Aiping</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>JiangXi Key Laboratory of Transfusion Medicine, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Zhanglin</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0001-8712-0264</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>JiangXi Key Laboratory of Transfusion Medicine, Nanchang, Jiangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cancer Biol Ther</MedlineTA>
        <NlmUniqueID>101137842</NlmUniqueID>
        <ISSNLinking>1538-4047</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C410167">AIM2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053468">CARD Signaling Adaptor Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C435692">NLRC4 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>148998-64-5</RegistryNumber>
          <NameOfSubstance UI="C076700">IFI16 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IT942ZTH98</RegistryNumber>
          <NameOfSubstance UI="D003474">Curcumin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D053468" MajorTopicYN="N">CARD Signaling Adaptor Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002135" MajorTopicYN="N">Calcium-Binding Proteins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003474" MajorTopicYN="Y">Curcumin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015470" MajorTopicYN="Y">Leukemia, Myeloid, Acute</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069292" MajorTopicYN="N">Pyroptosis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020298" MajorTopicYN="N">U937 Cells</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Curcumin</Keyword>
        <Keyword MajorTopicYN="N">GSDMD</Keyword>
        <Keyword MajorTopicYN="N">inflammasome</Keyword>
        <Keyword MajorTopicYN="N">leukemia</Keyword>
        <Keyword MajorTopicYN="N">pyroptosis</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>8</Hour>
          <Minute>40</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35435150</ArticleId>
        <ArticleId IdType="pmc">PMC9037542</ArticleId>
        <ArticleId IdType="doi">10.1080/15384047.2022.2058862</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Doucette K, Karp J, Lai C.. 
Advances in therapeutic options for newly diagnosed, high-risk AML patients. Ther Adv Hematol. 2021;12:20406207211001138. doi:10.1177/20406207211001138. PMID: 33995985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/20406207211001138</ArticleId>
            <ArticleId IdType="pmc">PMC8111550</ArticleId>
            <ArticleId IdType="pubmed">33995985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kayser S, Levis MJ. Advances in targeted therapy for acute myeloid leukaemia. Br J Haematol. 2018;180:484–500. doi:10.1111/bjh.15032. PMID: 29193012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjh.15032</ArticleId>
            <ArticleId IdType="pmc">PMC5801209</ArticleId>
            <ArticleId IdType="pubmed">29193012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. J Hematol Oncol. 2020;13:72. doi:10.1186/s13045-020-00908-z. PMID: 32513227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13045-020-00908-z</ArticleId>
            <ArticleId IdType="pmc">PMC7282046</ArticleId>
            <ArticleId IdType="pubmed">32513227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dohner H, Weisdorf DJ, Bloomfield CD, Longo DL. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–1152. doi:10.1056/NEJMra1406184. PMID: 26376137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1406184</ArticleId>
            <ArticleId IdType="pubmed">26376137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhatia M, Bhalerao M, Cruz-Martins N, Kumar D. Curcumin and cancer biology: focusing regulatory effects in different signalling pathways. Phytother Res. 2021;35(9):4913–4929. doi:10.1002/ptr.7121. PMID: 33837579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ptr.7121</ArticleId>
            <ArticleId IdType="pubmed">33837579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang W, Du M, Zhang S, Jiang H. Therapeutic effect of curcumin on oral diseases: a literature review. Phytother Res: PTR. 2020. doi:10.1002/ptr.6943. PMID: 33205472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ptr.6943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Kong Y, Liu S, Zeng L, Wan L, Zhang Z. Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway. Cancer Biol Ther. 2017;18:43–50. doi:10.1080/15384047.2016.1276129. PMID: 28071969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15384047.2016.1276129</ArticleId>
            <ArticleId IdType="pmc">PMC5323008</ArticleId>
            <ArticleId IdType="pubmed">28071969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients. 2019;11:2376. doi:10.3390/nu11102376. PMID: 31590362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu11102376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mortezaee K, Salehi E, Mirtavoos-Mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. Mechanisms of apoptosis modulation by curcumin: implications for cancer therapy. J Cell Physiol. 2019;234:12537–12550. doi:10.1002/jcp.28122. PMID: 30623450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.28122</ArticleId>
            <ArticleId IdType="pubmed">30623450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang WF, Gong YX, Li HF, Sun FL, Li WL, Chen DQ, Xie DP, Ren CX, Guo XY, Wang ZY, et al. Curcumin activates ROS signaling to promote pyroptosis in hepatocellular carcinoma HepG2 cells. In Vivo (Brooklyn). 2021;35:249–257. doi:10.21873/invivo.12253. PMID: 33402471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21873/invivo.12253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller JM, Thompson JK, MacPherson MB, Beuschel SL, Westbom CM, Sayan M, Shukla A. Curcumin: a double hit on malignant mesothelioma. Cancer Prev Res. 2014;7:330–340. doi:10.1158/1940-6207.CAPR-13-0259. PMID: 24431405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1940-6207.CAPR-13-0259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ta A, Vanaja SK. Inflammasome activation and evasion by bacterial pathogens. Curr Opin Immunol. 2021;68:125–133. doi:10.1016/j.coi.2020.11.006. PMID: 33338767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coi.2020.11.006</ArticleId>
            <ArticleId IdType="pmc">PMC7925435</ArticleId>
            <ArticleId IdType="pubmed">33338767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245–254. doi:10.1016/j.tibs.2016.10.004. PMID: 27932073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2016.10.004</ArticleId>
            <ArticleId IdType="pubmed">27932073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, Yu T, Wu X, Shi Y, Ma P, et al. Pyroptosis: a new frontier in cancer. Biomed Pharmacother. 2020;121:109595. doi:10.1016/j.biopha.2019.109595. PMID: 31710896.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109595</ArticleId>
            <ArticleId IdType="pubmed">31710896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia X, Wang X, Cheng Z, Qin W, Lei L, Jiang J, Hu J. The role of pyroptosis in cancer: pro-cancer or pro-”host”?
Cell Death Dis. 2019;10:650. doi:10.1038/s41419-019-1883-8. PMID: 31501419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-019-1883-8</ArticleId>
            <ArticleId IdType="pmc">PMC6733901</ArticleId>
            <ArticleId IdType="pubmed">31501419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruan J, Wang S, Wang J. Mechanism and regulation of pyroptosis-mediated in cancer cell death. Chem Biol Interact. 2020;323:109052. doi:10.1016/j.cbi.2020.109052. PMID: 32169591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cbi.2020.109052</ArticleId>
            <ArticleId IdType="pubmed">32169591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang YY, Liu XL, Zhao R. Induction of pyroptosis and its implications in cancer management. Front Oncol. 2019;9:971. doi:10.3389/fonc.2019.00971. PMID: 31616642.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2019.00971</ArticleId>
            <ArticleId IdType="pmc">PMC6775187</ArticleId>
            <ArticleId IdType="pubmed">31616642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, Reed C, Peguero E, de Stanchina E, Kentsis A, et al. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24:1151–1156. doi:10.1038/s41591-018-0082-y. PMID: 29967349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41591-018-0082-y</ArticleId>
            <ArticleId IdType="pmc">PMC6082709</ArticleId>
            <ArticleId IdType="pubmed">29967349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumari P, Russo AJ, Shivcharan S, Rathinam VA. AIM2 in health and disease: inflammasome and beyond. Immunol Rev. 2020;297:83–95. doi:10.1111/imr.12903. PMID: 32713036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imr.12903</ArticleId>
            <ArticleId IdType="pmc">PMC7668394</ArticleId>
            <ArticleId IdType="pubmed">32713036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalid N, Azimpouran M. Necrosis. StatPearls. Treasure Island (FL); 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen L, Weng B, Li H, Wang H, Li Q, Wei X, Deng H, Wang S, Jiang C, Lin R, et al. A thiopyran derivative with low murine toxicity with therapeutic potential on lung cancer acting through a NF-kappaB mediated apoptosis-to-pyroptosis switch. Apoptosis. 2019;24:74–82. doi:10.1007/s10495-018-1499-y. PMID: 30519834.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10495-018-1499-y</ArticleId>
            <ArticleId IdType="pubmed">30519834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243:206–214. doi:10.1111/j.1600-065X.2011.01044.x. PMID: 21884178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-065X.2011.01044.x</ArticleId>
            <ArticleId IdType="pmc">PMC3609431</ArticleId>
            <ArticleId IdType="pubmed">21884178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6–21. doi:10.1111/imr.12296. PMID: 25879280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imr.12296</ArticleId>
            <ArticleId IdType="pmc">PMC4400844</ArticleId>
            <ArticleId IdType="pubmed">25879280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013–1022. doi:10.1016/j.cell.2014.04.007. PMID: 24855941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.04.007</ArticleId>
            <ArticleId IdType="pubmed">24855941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupfer C, Kanneganti TD. Unsolved mysteries in NLR biology. Front Immunol. 2013;4:285. doi:10.3389/fimmu.2013.00285. PMID: 24062750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2013.00285</ArticleId>
            <ArticleId IdType="pmc">PMC3775000</ArticleId>
            <ArticleId IdType="pubmed">24062750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choubey D, Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett. 2008;119:32–41. doi:10.1016/j.imlet.2008.06.001. PMID: 18598717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imlet.2008.06.001</ArticleId>
            <ArticleId IdType="pmc">PMC2585765</ArticleId>
            <ArticleId IdType="pubmed">18598717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fink K, Grandvaux N. STAT2 and IRF9: beyond ISGF3. JakStat. 2013;2:e27521. doi:10.4161/jkst.27521. PMID: 24498542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/jkst.27521</ArticleId>
            <ArticleId IdType="pmc">PMC3906322</ArticleId>
            <ArticleId IdType="pubmed">24498542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al Mamun A, Mimi AA, Aziz MA, Zaeem M, Ahmed T, Munir F, Xiao J. Role of pyroptosis in cancer and its therapeutic regulation. Eur J Pharmacol. 2021;910:174444. doi:10.1016/j.ejphar.2021.174444. PMID: 34453928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2021.174444</ArticleId>
            <ArticleId IdType="pubmed">34453928</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
